Rwanda

With funding from the U.S. Agency for International Development (USAID), RISE is working in select countries, including Rwanda, to address the COVID-19 pandemic. In line with ministry of health priorities in each country, RISE’s COVID-19 response support may include: assisting in the planning and rollout of national vaccine plans, including ensuring health care workers are prepared to implement and monitor this plan; providing focused and clinically relevant capacity building for clinicians providing COVID-19 case management; strengthening the oxygen ecosystem; and supporting health care workers in oxygen conservation, rationalization and non-invasive respiratory care.

RISE is a five-year global project—funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and USAID—that works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights, and Mann Global Health. For the COVID-19 ventilator technical assistance effort, RISE is also collaborating with the University of California San Francisco, World Federation of Societies of Anesthesiologists (via the GH STAR project), FHI 360 (via the EpiC Project) and Johns Hopkins University emergency medicine and critical care staff.

Impact Malaria is a global project of the U.S. President’s Malaria Initiative to reduce mortality and morbidity caused by malaria. Implemented by a consortium of organizations led by PSI, the project is funded by the U.S. Agency for International Development. In close collaboration with Rwanda’s National Malaria Control Program, other sections of the Ministry of Health and various implementing partners, Impact Malaria is designed to improve malaria service delivery via the following objectives: 1) improve the quality of and access to malaria case management and prevention of malaria in pregnancy; 2) improve the quality of and access to other malaria drug-based approaches and provide support to pilot/scale up newer malaria drug-based approaches; and 3) provide global technical leadership, support operational research and advance program learning.

With funding from Belgian development agency Enabel, Jhpiego is implementing a three-year project targeting seven health districts. The project’s objective is to ensure accessible, evidence-based, improved and innovative maternal, neonatal, child, sexual and reproductive health services in these districts. In addition, the project seeks to increase citizens’ participation and engagement in development in alignment with the current national Health Sector Strategic Plan 4.

With funding from the Bill & Melinda Gates Foundation, Jhpiego is conducting a health facility survey in Rwanda with the goal of improving malaria case management. In partnership with the Malaria and Other Parasitic Diseases Division of the Government of Rwanda, the U.S. President’s Malaria Initiative and the U.S. Centers for Disease Control and Prevention, Jhpiego is designing and implementing the study, which will measure progress made in outpatient malaria case management against national malaria treatment guidelines. Data from this study will benefit Rwanda’s national malaria control program by: informing the development of malaria case management training and supervision strategies; providing data on which antimalarial and rapid diagnostic tests are ideal for the country; and characterizing the degree to which routine health facility data reflect the true malaria burden.

Jhpiego is providing technical assistance to support event-based surveillance in Rwanda to carry out a range of complex epidemiologic and surveillance activities associated with event-based surveillance systems and alert and response operations at Rwanda Biomedical Center. This work is funded by the CDC Foundation.